| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2017 ( Subtotal = $0 ) |
| 2017 | 2014 | MOLECULAR TARGETING TECHNOLOGIES, INC. | 833 LINCOLN AVE UNIT 9 | WEST CHESTER | PA | 19380 | CHESTER | USA | Allergy and Infectious Diseases Research | 000 | 5 | 11/4/2016 | NON-COMPETING CONTINUATION | $0 |
|
 | Issue Date FY: 2014 ( Subtotal = $833,079 ) |
| 2014 | 2014 | MOLECULAR TARGETING TECHNOLOGIES INC | 833 LINCOLN AVE UNIT 9 | WEST CHESTER | PA | 19380 | CHESTER | USA | Allergy and Infectious Diseases Research | 000 | 5 | 5/21/2014 | NON-COMPETING CONTINUATION | $833,079 |
|
 | Issue Date FY: 2013 ( Subtotal = $858,482 ) |
| 2013 | 2013 | MOLECULAR TARGETING TECHNOLOGIES INC | 833 LINCOLN AVE UNIT 9 | WEST CHESTER | PA | 19380 | CHESTER | USA | Allergy and Infectious Diseases Research | 000 | 4 | 5/14/2013 | NON-COMPETING CONTINUATION | $858,482 |
|
 | Issue Date FY: 2012 ( Subtotal = $817,599 ) |
| 2012 | 2012 | MOLECULAR TARGETING TECHNOLOGIES INC | 833 LINCOLN AVE UNIT 9 | WEST CHESTER | PA | 19380 | CHESTER | USA | Allergy and Infectious Diseases Research | 000 | 3 | 6/21/2012 | COMPETING CONTINUATION | $817,599 |
|
|